论文信息 - Sugammadex: A New Reversal Drug With the Same Risk - A Continued Need for Neuromuscular Blockade Monitoring - 字舞流文

Sugammadex: A New Reversal Drug With the Same Risk - A Continued Need for Neuromuscular Blockade Monitoring

J. Sparling | Samuel Lee | David Dunipace

[1] S. Lengyel,et al. Reversal of Vecuronium-induced Neuromuscular Blockade with Low-dose Sugammadex at Train-of-four Count of Four: A Randomized Controlled Trial , 2017, Anesthesiology.

[2] A. Afshari,et al. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. , 2017, The Cochrane database of systematic reviews.

[3] M. Ozaki,et al. Reversal with Sugammadex in the Absence of Monitoring Did Not Preclude Residual Neuromuscular Block , 2013, Anesthesia and analgesia.